A clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatment

被引:29
作者
Braitstein, Paula [1 ,2 ,3 ,4 ]
Siika, Abraham [1 ,2 ,3 ]
Hogan, Joseph [3 ,5 ]
Kosgei, Rose [3 ]
Sang, Edwin [3 ]
Sidle, John [1 ,2 ,3 ]
Wools-Kaloustian, Kara [1 ,2 ,3 ]
Keter, Alfred [3 ]
Mamlin, Joseph [1 ,2 ,3 ]
Kimaiyo, Sylvester [2 ,3 ]
机构
[1] Indiana Univ, Sch Med, Indianapolis, IN 46202 USA
[2] Moi Univ, Sch Med, Eldoret, Kenya
[3] Acad Model Providing Access Healthcare AMPATH, Eldoret, Kenya
[4] Regenstrief Inst Inc, Indianapolis, IN USA
[5] Brown Univ, Dept Biostat, Providence, RI 02912 USA
关键词
Antiretrovirals; Mortality; Losses to follow up; Adherence; Models of care; Africa; IMMUNE RECONSTITUTION DISEASE; HIV-1-INFECTED PATIENTS; COLLABORATIVE ANALYSIS; TREATMENT PROGRAMS; FOLLOW-UP; THERAPY; SURVIVAL; TUBERCULOSIS; EXPERIENCE; MORBIDITY;
D O I
10.1186/1758-2652-15-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: In resource-poor settings, mortality is at its highest during the first 3 months after combination antiretroviral treatment (cART) initiation. A clear predictor of mortality during this period is having a low CD4 count at the time of treatment initiation. The objective of this study was to evaluate the effect on survival and clinic retention of a nurse-based rapid assessment clinic for high-risk individuals initiating cART in a resource-constrained setting. Methods: The USAID-AMPATH Partnership has enrolled more than 140,000 patients at 25 clinics throughout western Kenya. High Risk Express Care (HREC) provides weekly or bi-weekly rapid contacts with nurses for individuals initiating cART with CD4 counts of <= 100 cells/mm(3). All HIV-infected individuals aged 14 years or older initiating cART with CD4 counts of <= 100 cells/mm(3) were eligible for enrolment into HREC and for analysis. Adjusted hazard ratios (AHRs) control for potential confounding using propensity score methods. Results: Between March 2007 and March 2009, 4,958 patients initiated cART with CD4 counts of <= 100 cells/mm(3). After adjusting for age, sex, CD4 count, use of cotrimoxazole, treatment for tuberculosis, travel time to clinic and type of clinic, individuals in HREC had reduced mortality (AHR: 0.59; 95% confidence interval: 0.45-0.77), and reduced loss to follow up (AHR: 0.62; 95% CI: 0.55-0.70) compared with individuals in routine care. Overall, patients in HREC were much more likely to be alive and in care after a median of nearly 11 months of follow up (AHR: 0.62; 95% CI: 0.57-0.67). Conclusions: Frequent monitoring by dedicated nurses in the early months of cART can significantly reduce mortality and loss to follow up among high-risk patients initiating treatment in resource-constrained settings.
引用
收藏
页数:8
相关论文
共 37 条
[1]   Impact of vital status investigation procedures on estimates of survival in cohorts of HIV-infected patients from sub-Saharan Africa [J].
Anglaret, X ;
Toure, S ;
Gourvellec, G ;
Tchehy, A ;
Zio, L ;
Zaho, M ;
Kassi, MC ;
Lehou, J ;
Coulibaly, H ;
Seyler, C ;
N'Dri-Yoman, T ;
Salamon, R ;
Chêne, G .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 35 (03) :320-323
[2]  
[Anonymous], 2011, GLOB HIV AIDS RESP E
[3]  
Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2
[4]   Mortality of Patients Lost to Follow-Up in Antiretroviral Treatment Programmes in Resource-Limited Settings: Systematic Review and Meta-Analysis [J].
Brinkhof, Martin W. G. ;
Pujades-Rodriguez, Mar ;
Egger, Matthias .
PLOS ONE, 2009, 4 (06)
[5]   Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa [J].
Coetzee, D ;
Hildebrand, K ;
Boulle, A ;
Maartens, G ;
Louis, F ;
Labatala, V ;
Reuter, H ;
Ntwana, N ;
Goemaere, E .
AIDS, 2004, 18 (06) :887-895
[6]   Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy:: a collaborative analysis of prospective studies [J].
Egger, M ;
May, M ;
Chêne, G ;
Phillips, AN ;
Ledergerber, B ;
Dabis, F ;
Costagliola, D ;
Monforte, AD ;
de Wolf, F ;
Reiss, P ;
Lundgren, JD ;
Justice, AC ;
Staszewski, S ;
Leport, C ;
Hogg, RS ;
Sabin, CA ;
Gill, MJ ;
Salzberger, B ;
Sterne, JAC .
LANCET, 2002, 360 (9327) :119-129
[7]   Responding to the HIV pandemic: The power of an academic medical partnership [J].
Einterz, Robert M. ;
Kimaiyo, Sylvester ;
Mengech, Haroun N. K. ;
Khwa-Otsyula, Barasa O. ;
Esamai, Fabian ;
Quigley, Fran ;
Mamlin, Joseph J. .
ACADEMIC MEDICINE, 2007, 82 (08) :812-818
[8]   Early initiation of antiretroviral therapy and associated reduction in mortality, morbidity and defaulting in a nurse-managed, community cohort in Lesotho [J].
Ford, Nathan ;
Kranzer, Katharina ;
Hilderbrand, Katherine ;
Jouquet, Guillaume ;
Goemaere, Eric ;
Vlahakis, Nathalie ;
Trivino, Laura ;
Makakole, Lipontso ;
Bygrave, Helen .
AIDS, 2010, 24 (17) :2645-2650
[9]  
Fulton BD, HUM RESOUR HLTH, V9, P1
[10]   Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men [J].
Hernán, MA ;
Brumback, B ;
Robins, JM .
EPIDEMIOLOGY, 2000, 11 (05) :561-570